LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemia.

Acute myelocytic leukemia (AML) is the most common type of acute leukemia. Long non‑coding RNAs (lncRNAs) serve an important role in regulating gene expression through chromatin modification, transcription and post‑transcriptional processing. LncRNA H19 was considered as an independent prognostic marker for patients with tumors. The expression of lncRNA H19 was identified to be significantly upregulated in bone marrow samples from patients with AML‑M2. Furthermore, it was demonstrated that the knockdown of lncRNA H19 resulted in increased expression of hsa‑microRNA (miR)‑19a/b and decreased expression of inhibitor of DNA binding 2 (ID2) in AML cells. The knockdown of lncRNA H19 inhibited the proliferation of AML cells in vitro, which could be partially reversed by ID2 overexpression. Furthermore, the results of the bioinformatic analysis revealed potential hsa‑miR‑19a/b‑3p binding sites in lncRNA H19 and ID2. Altogether, the results of the present study suggest that lncRNA H19 regulates the expression of ID2 through competitive binding to hsa‑miR‑19a and hsa‑miR‑19b, which may serve a role in AML cell proliferation.

[1]  Ming Liu,et al.  Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis , 2016, Oncotarget.

[2]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[3]  P. Stadler,et al.  RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription , 2007, Science.

[4]  L Wang,et al.  Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma. , 2015, Neoplasma.

[5]  Guoxin Zhang,et al.  The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer , 2015, Cellular Physiology and Biochemistry.

[6]  Guoxin Zhang,et al.  Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer , 2015, Scientific Reports.

[7]  Wei Li,et al.  c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer , 2016, Tumor Biology.

[8]  Li Zhang,et al.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer , 2015, Oncotarget.

[9]  L. Kiemeney,et al.  Polymorphisms in the H19 gene and the risk of bladder cancer. , 2008, European urology.

[10]  Yingying Lian,et al.  Role of human noncoding RNAs in the control of tumorigenesis , 2009, Proceedings of the National Academy of Sciences.

[11]  M. Waye,et al.  H19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNA , 2016, Scientific Reports.

[12]  Sergio Verjovski-Almeida,et al.  Long intronic noncoding RNA transcription: expression noise or expression choice? , 2009, Genomics.

[13]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[14]  Xin Hu,et al.  ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression , 2014, OncoTargets and therapy.

[15]  M. Werner,et al.  ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes , 2013, Histochemistry and Cell Biology.

[16]  T. Xia,et al.  Long noncoding RNA associated-competing endogenous RNAs in gastric cancer , 2014, Scientific Reports.

[17]  F. Ferrara,et al.  Acute myeloid leukaemia in adults , 2013, The Lancet.

[18]  Xin Hu,et al.  iD 2 predicts poor prognosis in breast cancer , especially in triple-negative breast cancer , and inhibits e-cadherin expression , 2014 .

[19]  D. Monté,et al.  H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1* , 2005, Journal of Biological Chemistry.

[20]  David I. Smith,et al.  Long, abundantly expressed non-coding transcripts are altered in cancer. , 2008, Human molecular genetics.

[21]  Jun He,et al.  Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. , 2015, International journal of clinical and experimental pathology.

[22]  Wei Wang,et al.  Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. , 2013, Cancer letters.

[23]  J. Rinn,et al.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.

[24]  Yi-Qing Zheng,et al.  Chinese a Nti鄄 Cancer a Ssociation , 2007 .

[25]  E. Freireich,et al.  HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. , 1988, Blood.

[26]  Jianxin Qiu,et al.  Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression , 2013, The FEBS journal.